ERS Genomics appoints vice-president of IP
23-09-2020
Broad Institute presses for CRISPR settlement after EPO revocation
23-01-2020
Broad hits out at UC Berkeley in latest CRISPR battle
02-08-2019
Ken Wolter / Shutterstock.com
The Broad Institute and ERS Genomics, a company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, have both claimed victory in the latest round of the CRISPR inventorship battle.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
PTAB, USPTO, CRISPR, Broad Institute, UC Berkeley, MIT, Harvard, CRISPR Cas9, patent, genome editing, inventorship, ERS Genomics
